Full-Time

Data & AI Engineer

Posted on 8/6/2026

Deadline 8/7/26
Philips

Philips

Healthcare technology for diagnosis, care, wellness

No salary listed

Bengaluru, Karnataka, India

Hybrid

Office-based role with at least three days per week in person.

Bachelor's, Master's

Category
Data & Analytics (2)
,
Required Skills
LLM
Scikit-learn
Kubernetes
MLOps
Microsoft Azure
FastAPI
Python
GitHub Actions
NoSQL
TensorFlow
Git
PyTorch
SQL
Machine Learning
MLflow
ETL
Data Engineering
Docker
RAG
Cybersecurity
Microservices
AWS
REST APIs
Data Modeling
DevOps
Data Analysis
Google Cloud Platform
Requirements
  • A Bachelor's or Master's degree in Computer Science, Artificial Intelligence, Data Science, Information Technology, Software Engineering, Statistics, Mathematics, or a related discipline.
  • For candidates with a Bachelor's degree, 3–6 years of experience in Data Engineering, AI Engineering, Machine Learning Engineering, Software Engineering, or related fields.
  • Alternatively, a vocational or equivalent qualification with at least 4 years of relevant experience in Data Engineering, AI Engineering, Analytics, Machine Learning, or Software Development.
  • Experience with Azure AI Services, Azure Machine Learning, Microsoft Fabric, or Amazon Bedrock, including model orchestration, agents, and knowledge bases on Bedrock.
  • Experience taking Generative AI or agentic AI applications from proof of concept to production in an enterprise setting.
  • Knowledge of Responsible AI, AI governance, cybersecurity, and data privacy practices, including GDPR and healthcare data handling.
  • Programming proficiency in Python and SQL.
  • Experience with ETL/ELT, data pipelines, and data modelling for structured and unstructured service data.
  • Experience with Scikit-learn and TensorFlow or PyTorch.
  • Experience with LLMs, prompt engineering, Retrieval-Augmented Generation, vector databases, and agentic AI frameworks.
  • Experience with Azure, AWS, or Google Cloud Platform.
  • Experience with MLflow, Docker, Kubernetes, GitHub Actions or Azure DevOps, and CI/CD.
  • Experience with SQL, NoSQL, and vector databases.
  • Experience developing REST APIs with FastAPI or similar frameworks.
  • Experience using Git.
Responsibilities
  • Design, develop, and deploy production-grade data and AI solutions across the MR service AI portfolio, including predictive failure and remote-resolution models, AI-driven parts recommendation, root-cause analytics for rework reduction, and Generative AI applications for contract and entitlement analytics.
  • Build and maintain robust data pipelines and data models over ITSM cases, remote diagnostics and machine logs, parts data, and contract data.
  • Develop, integrate, and operationalise machine learning models, large language models, Retrieval-Augmented Generation pipelines, and agentic AI workflows into service tools used by field service engineers and remote service engineers worldwide.
  • Take proof-of-concept solutions to minimum viable product and productization by hardening prototypes into validated, monitored, supportable enterprise solutions.
  • Implement AI engineering practices including MLOps/LLMOps, CI/CD, automated testing, monitoring, model versioning, and governance for a regulated healthcare environment.
  • Develop APIs, microservices, and cloud-native AI services for scalable deployment across enterprise and service platforms.
  • Monitor model performance in the field and retrain and continuously optimise models for accuracy, latency, cost, and reliability against measurable service outcomes.
  • Embed Responsible AI through data privacy, security, explainability, auditability, and compliance requirements consistent with MedTech and Philips AI governance standards.
  • Collaborate with Data Scientists, System Architects, Service Information Architects, Product Owners, and external delivery partners to translate service business problems into engineered solutions.
  • Evaluate emerging AI technologies and frameworks and contribute to code reviews, documentation, knowledge sharing, and the engineering standards of the team.
Desired Qualifications
  • Exposure to healthcare, MedTech, or other regulated industries.
  • Familiarity with medical device service operations, Internet of Things and remote diagnostics data, or field service workflows.
  • Experience with time-series, classification, and natural language processing on operational data.
  • Comfort working in a globally distributed, remote-first team across India, Europe, and North America.
  • Strong problem-solving, collaboration, and communication abilities, including working directly with service domain experts and translating their knowledge into AI solutions.

Philips develops health technology across professional medical devices, connected care, and consumer health products. Its offerings include diagnostic imaging and image-guided therapy, patient monitoring and clinical informatics, and everyday wellness products like oral and personal care. The company increasingly delivers integrated solutions through a Healthcare-as-a-Service subscription model and long-term partnerships with hospitals and health systems. Its aim is to improve people’s health and well-being by making advanced health technology easier to access and integrate into care.

Company Size

N/A

Company Stage

IPO

Headquarters

Andover, Minnesota

Founded

1891

Simplify Jobs

Simplify's Take

What believers are saying

  • May 18, 2026 Stockholm selected Philips for hospital-at-home coverage across up to 15,000 patients annually.
  • Q1 2026 sales grew 4%, and Philips reiterated 2026 guidance on May 13, 2026.
  • 2025 free cash flow reached EUR 512 million, supporting investment and shareholder returns.

What critics are saying

  • August 2026 MDL still holds 624 Philips CPAP cases, extending legal drag.
  • January 19, 2026 settlement covers economics only; DOJ consent-decree talks still threaten Respironics.
  • A Respironics compliance failure can block U.S. sleep-device sales and tarnish Philips brand.

What makes Philips unique

  • June 4, 2026 WellSpan alliance makes Philips preferred vendor across CT, MR, X-ray, ultrasound, image-guided therapy.
  • August 6, 2026 ecosystem partnerships connect Philips monitoring from hospital beds to homes.
  • Philips combines diagnosis, connected care, and personal health across 64,317 employees at Q1 2026.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

401(k) Retirement Plan

401(k) Company Match

Unlimited Paid Time Off

Health Savings Account/Flexible Spending Account

Company News

PR Newswire
May 28th, 2026
Remote patient monitoring market to reach $117.9B by 2033 amid digital healthcare transformation

The global remote patient monitoring market is expected to grow from $67.3 billion in 2026 to $117.9 billion by 2033, registering a CAGR of 8.3%. Growth is driven by rising chronic disease prevalence, expanding telehealth services and increasing demand for home-based healthcare solutions. Devices and hardware account for nearly 38% of market share, led by connected blood pressure monitors, glucometers and wearable health trackers. North America holds approximately 41% of the global market, supported by strong digital healthcare infrastructure and favourable reimbursement policies. Asia Pacific is emerging as the fastest-growing region, driven by healthcare digitisation, telemedicine expansion and rising smartphone penetration. Leading players include Philips Healthcare, Medtronic, GE HealthCare and Abbott Laboratories, focusing on AI integration and cloud connectivity to enhance remote care delivery.

HIT Consultant
Apr 12th, 2024
Philips Respironics Reaches Final Agreement With Us Regulators On Sleep Apnea Device Recall

<img src="https://hitconsultant.net/wp-content/uploads/2024/04/Philips.webp" alt="Philips Respironics Reaches Final Agreement with US Regulators on Sleep Apnea Device Recall. " class="wp-image-78777" srcset="https://hitconsultant.net/wp-content/uploads/2024/04/Philips.webp 700w, https://hitconsultant.net/wp-content/uploads/2024/04/Philips-300x161.webp 300w, https://hitconsultant.net/wp-content/uploads/2024/04/Philips-290x155.webp 290w" sizes="(max-width: 700px) 100vw, 700px">What You Should Know: – Philips Respironics, a subsidiary of Royal Philips, has finalized a consent decree with the US Department of Justice (DOJ) and Food and Drug Administration (FDA) to address issues raised during a 2021 inspection of a Philips facility in Pennsylvania.– The agreement focuses on Philips Respironics’ operations in the US, particularly regarding the recall of certain sleep and respiratory care devices.– The company’s focus will now be on completing remediation efforts, ensuring patient safety, and regaining regulatory approval to resume sales of new devices in the US.Focus on Remediation and ComplianceThe consent decree outlines a roadmap for Philips Respironics to:Prioritize Recall Remediation: Philips will continue efforts to remediate millions of sleep apnea and respiratory care devices recalled in June 2021 due to potential health risks associated with degraded sound abatement foam.Independent Oversight: Independent experts will be brought in to review recall remediation efforts and ensure Philips Respironics’ business operations comply with FDA regulations.Continued Patient Support: Philips Respironics can continue servicing existing devices in the hands of patients and healthcare providers. Additionally, they can sell accessories, consumables, and replacement parts for these devices.Sales Restrictions Remain in USThe FDA has not yet authorized Philips Respironics to resume sales of new CPAP, BiPAP, or other respiratory care devices in the US. This restriction will remain in place until Philips meets the requirements outlined in the consent decree.Global Sales Continue with RestrictionsPhilips Respironics can continue to sell new devices, accessories, consumables, and replacement parts outside the US,  subject to specific requirements.Safety of Devices with New Foam ConfirmedPhilips Respironics has conducted tests on devices using a new silicone sound abatement foam and found no safety issues. Patients can continue to use these devices following the instructions for use.Financial ImpactPhilips anticipates incurring costs associated with remediation activities and profit disgorgement related to US sales. These costs are estimated at 100 basis points in 2024.  The company’s previously announced 2023-2025 financial outlook remains unchanged,  already factoring in the consent decree. “Strengthening patient safety and quality remains Philips’ highest priority and the increased scrutiny will help us to improve even more

Goodrich Pharmacy
Jan 29th, 2024
Phillips Suspends U.S. Sales of CPAP, Ventilator Machines After Recall

Following a recall of millions of its breathing machines that began in mid-2021, Phillips Respironics announced Monday that it would halt sales of all such machines within the United States.

YourLawyer.com
Mar 23rd, 2023
Sleep Apnea Patients Suffer While Waiting To Receive Their Repaired Philips CPAP Machines

In June of 2021, Philips began a recall of over five million of its breathing devices due to toxic fume and substances emanating from the devices’ sound abatement foam.

Digital Journal
Jan 13th, 2023
Ultrasound Market Share | Market | Report | Analysis 2032 | Key Players: Fujifilm Holdings Corporation, Analogic Corporation, Siemens Healthcare among others

February 2019 – Koninklijke Philips launched the EPIQ Elite ultrasound system in the market.

INACTIVE